Active Biotech AB (publ) (ACTI.ST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Helen Tuvesson Ph.D. | President & CEO | 3.88M | -- | 1962 |
| Mr. Hans Kolam | Chief Financial Officer | -- | -- | 1951 |
| Dr. Erik Vahtola M.D., Ph.D. | Chief Medical Officer | -- | -- | 1976 |
Active Biotech AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas ans Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.
Corporate Governance
Upcoming Events
May 8, 2025 at 10:59 AM UTC
Active Biotech AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available